Nod sought for P-3 booster trial | India News

0
53


NEW DELHI: Hyderabad-based pharmaceutical company Biological E has applied to India’s drug regulator for permission to conduct phase 3 clinical trial for its Covid-19 vaccine. Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Currently, phase 2/3 clinical trials of Corbevax, a RBD A protein subunit vaccine is being prepared for use in adults.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here